Pharmazell Group

Raubling, Germany Founded: 1946 • Age: 80 yrs Acquired By Bridgepoint Capital
Active pharmaceutical ingredients are manufactured by Pharmazell Group.

About Pharmazell Group

Pharmazell Group is a Healthcare company based in Raubling (Germany) founded in 1946, and was acquired by Bridgepoint Capital in February 2020. Active pharmaceutical ingredients are manufactured by Pharmazell Group. Its Indian entity Pharmazell (India) Private Limited reported revenue of β‚Ή525 Cr. Its focus areas include Biopharma Outsourcing, CDMO, Small Molecules & Peptides and API Production.

Company details

The Pharmazell Group was established in 1946 in Raubling, Germany, where active pharmaceutical ingredients are produced for the global pharmaceutical sector. Operations center on the development and manufacturing of APIs, with a focus on quality standards required by the industry. The company is directed by Managing Director Anant Barbadikar. Geographic emphasis remains on European facilities, supporting supply chains for international clients in drug formulation.

Key Metrics
  • Indian entity revenue
    ₹525 Cr

    FY 2025 · +3% YoY

  • Indian entity net profit
    ₹54.82 Cr

    FY 2025 · 11% margin

  • Indian entity EBITDA
    ₹101 Cr

    FY 2025 · 20% margin

  • Investors
    EQT

    & 3 more

  • Acquired by
    Bridgepoint Capital

    & 2 more

    (Feb 2020)

Apps and channels of Pharmazell Group

its YouTube channel Axplora has 122 subscribers and 17 videos.

Axplora
YouTube 122 subscribers 17 videos Science & Technology
Open channel

Videos from Pharmazell Group

The most watched videos on Pharmazell Group's YouTube channel, Axplora (122 subscribers). Click a video to play it here.

Talenrama #2 Axplora Le Mans
5.7K views
Axplora Origins: three legacies, one company
1.2K views
Talenrama #3 Axplora Le Mans (Fr)
796 views
Axplora Is Born
657 views

More on Axplora.

Funding Insights of Pharmazell Group

  • Total Rounds 2
  • Investors Count 2

All 2 funding rounds of Pharmazell Group with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Aug 2007Private Equity Round–Apheon
–
May 2007Private Equity Round–EQT
–
Valuation history

4 investors in total: 4 institutional.

Investors in Pharmazell Group

Pharmazell Group has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include EQT, Deutsche Private Equity and Bridgepoint Capital.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Apheon is engaged in private equity investments across Europe.
apheon.com
EQT is recognized as a global investment organization focused on value creation.
1994eqtgroup.comStockholm, Sweden
Private equity firm
2007dpe.deMunich, Germany
Middle-market businesses up to €1 billion are acquired pan-Europe.
1984bridgepoint.euFrankfurt, Germany
Premium access

Investor details for Pharmazell Group

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Pharmazell (India) Private Limited (Pharmazell Group)

Pharmazell (India) Private Limited is the primary company behind Pharmazell Group. The board of Pharmazell (India) Private Limited currently have 4 directors; the longest-serving is Anant Dattatray Barbadikar, appointed in 2010. 8 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Anant Dattatray Barbadikar
DIN 01867501
Managing Director19 Feb 201016 yrs 8 moPharmazell (India) Private Limited
Nagarajan Karthik
DIN 09066728
Whole-time director01 Apr 20242 yrs 7 moPharmazell (India) Private Limited
Appa Rao Suryadevara
DIN 10538675
Whole-time director01 Apr 20242 yrs 7 moPharmazell (India) Private Limited
Sukumar Mani
DIN 10531760
Whole-time director01 Apr 20242 yrs 7 moPharmazell (India) Private Limited

People of Pharmazell Group

1 people are tracked at Pharmazell Group (1 in leadership).

NameRoleGroup
Managing DirectorLeadership
Premium access

Complete people profiles for Pharmazell Group

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Pharmazell Group

Figures of Pharmazell (India) Private Limited, the primary company behind Pharmazell Group, for FY 2025. Revenue was ₹525 Cr (+3% year on year). Net profit was ₹54.82 Cr (11% margin). EBITDA was ₹101 Cr (20% margin). Revenue has grown at a compounded annual rate of +13% over three years and +6% over five years.

  • ₹525 CrRevenue · FY 2025 · +3% YoY
  • ₹54.82 CrNet profit · 11% margin
  • ₹101 CrEBITDA · 20% margin
  • ₹10.92 CrPaid-up capital
  • 536Employees (provident fund records)
  • +13%Revenue CAGR, 3 years
  • +6%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Pharmazell (India) Private Limited are on its company page.

Premium access

Detailed financial statements for Pharmazell Group

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of Pharmazell Group

6 dated milestones of Pharmazell Group across 74 years, from founding to its latest funding, stage changes and deals.

  1. Founded Pharmazell Group is founded.
  2. Funding First funding round.
  3. Funding Latest funding round, Private Equity Round,.
  4. Exit Acquired by Apheon.
  5. Exit Acquired by Deutsche Private Equity.
  6. Exit Acquired by Bridgepoint Capital.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Pharmazell Group

PharmaZell and Novasep merge
Chemanager-Online β€’ 4 years ago
Bridgepoint to acquire PharmaZell
Bridgepoint β€’ 6 years ago
PharmaZell Group acquired by Bridgepoint
Pharmazell-Group β€’ 6 years ago
Premium access

Complete news archive for Pharmazell Group

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pharmazell Group

Pharmazell Group was founded in 1946 and raised its 1st funding round 61 years after it was founded.

Pharmazell Group is headquartered in Raubling, Germany. It is registered at Raubling, Bayern, Germany.

The primary company behind Pharmazell Group, Pharmazell (India) Private Limited, reported revenue of β‚Ή525 Cr for FY 2025, up 3% year on year.

The Pharmazell Group was established in 1946 in Raubling, Germany, where active pharmaceutical ingredients are produced for the global pharmaceutical sector. Operations center on the development and manufacturing of APIs, with a focus on quality standards required by the industry. The company is directed by Managing Director Anant Barbadikar. Geographic emphasis remains on European facilities, supporting supply chains for international clients in drug formulation.

Pharmazell Group has 4 investors. Key investors include EQT, Deutsche Private Equity, Bridgepoint Capital, and Apheon.

Pharmazell Group operates through Pharmazell (India) Private Limited.

Yes. Pharmazell Group was acquired by Bridgepoint Capital in February 2020.

The legal entities of Pharmazell Group currently have 5 directors, including Nagarajan Karthik, Durai Raj Sampath Kumar, Appa Rao Suryadevara and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available